Synaptogenix, Inc.
SNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $8 | $43 |
| - Cash | $18 | $29 | $37 | $34 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$13 | -$25 | -$30 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$13 | -$8 | -$16 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$13 | -$6 | -$5 | -$13 |
| % Margin | – | – | – | – |
| EPS Diluted | -10.99 | -29.56 | -20.35 | -62.87 |
| % Growth | 62.8% | -45.3% | 67.6% | – |
| Operating Cash Flow | -$5 | -$5 | -$11 | -$9 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$5 | -$11 | -$9 |